| Форма представления | Статьи в зарубежных журналах и сборниках |
| Год публикации | 2016 |
| Язык | английский |
|
Есин Олег Радиевич, автор
Есин Радий Германович, автор
Хайруллин Ильшат Хамзович, автор
|
|
Абакумова Анна Александровна, автор
|
| Библиографическое описание на языке оригинала |
Khairullin I., Abakumova A., Esin R., Esin O. The Influence of Diabetes Mellitus Duration and Type of Therapy on Cognitive Decline. BioNanoSci. (2016). doi:10.1007/s12668-016-0345-3 |
| Аннотация |
We studied 120 patients with compensated diabetes mellitus type 2 (DM-2). The inclusion criterion was the absence of memory loss complaints from the patient and/or his/her relatives. The exclusion criteria were diabetes decom?pensation, myocardial infarction and/or stroke in anamnesis, glomerular filtration rate below 60 ml/min, the presence of proliferative retinopathy, and/or other endocrine diseases. To diagnose the cognitive decline (CD) we used Mini-Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA test), Trail Making Test (parts A and B). 77.5 % patients with type 2 diabetes out of 120 had mod?erate CD; 5 % had a significant CD (dementia). |
| Ключевые слова |
Diabetes mellitus type 2, Diabetic encephalopathy, Cognitive decline, Dementia, Insulin resistance |
| Название журнала |
BioNanoScience
|
| Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на эту карточку |
https://repository.kpfu.ru/?p_id=144718 |
Полная запись метаданных  |
| Поле DC |
Значение |
Язык |
| dc.contributor.author |
Есин Олег Радиевич |
ru_RU |
| dc.contributor.author |
Есин Радий Германович |
ru_RU |
| dc.contributor.author |
Хайруллин Ильшат Хамзович |
ru_RU |
| dc.contributor.author |
Абакумова Анна Александровна |
ru_RU |
| dc.date.accessioned |
2016-01-01T00:00:00Z |
ru_RU |
| dc.date.available |
2016-01-01T00:00:00Z |
ru_RU |
| dc.date.issued |
2016 |
ru_RU |
| dc.identifier.citation |
Khairullin I., Abakumova A., Esin R., Esin O. The Influence of Diabetes Mellitus Duration and Type of Therapy on Cognitive Decline. BioNanoSci. (2016). doi:10.1007/s12668-016-0345-3 |
ru_RU |
| dc.identifier.uri |
https://repository.kpfu.ru/?p_id=144718 |
ru_RU |
| dc.description.abstract |
BioNanoScience |
ru_RU |
| dc.description.abstract |
We studied 120 patients with compensated diabetes mellitus type 2 (DM-2). The inclusion criterion was the absence of memory loss complaints from the patient and/or his/her relatives. The exclusion criteria were diabetes decom?pensation, myocardial infarction and/or stroke in anamnesis, glomerular filtration rate below 60 ml/min, the presence of proliferative retinopathy, and/or other endocrine diseases. To diagnose the cognitive decline (CD) we used Mini-Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA test), Trail Making Test (parts A and B). 77.5 % patients with type 2 diabetes out of 120 had mod?erate CD; 5 % had a significant CD (dementia). |
ru_RU |
| dc.language.iso |
ru |
ru_RU |
| dc.subject |
Diabetes mellitus type 2 |
ru_RU |
| dc.subject |
Diabetic encephalopathy |
ru_RU |
| dc.subject |
Cognitive decline |
ru_RU |
| dc.subject |
Dementia |
ru_RU |
| dc.subject |
Insulin resistance |
ru_RU |
| dc.title |
The Influence of Diabetes Mellitus Duration and Type of Therapy on Cognitive Decline. |
ru_RU |
| dc.type |
Статьи в зарубежных журналах и сборниках |
ru_RU |
|
EN 
中文 
ES 
Карта сайта
